wattAshton The U.S. Food and Drug Administration confirmed Tuesday that agency testing of commercially purchased pasteurized milk found genetic evidence of the H5N1 avian influenza virus. But tests using the …
Patients with advanced HER2-positive cancer now have new treatment options. The FDA recently announced the expansion of approval of Enhertu, making it the first tumor-agnostic HER2-targeted therapy. Enhertu was previously …
A group of researchers has urged U.S. regulators to withdraw approval of a test used to predict the risk of opioid addiction, saying government health programs should not pay for …
Pictured: Cell Therapy Concept/iStock, Meletios Verras Last month, the FDA announced it was reviewing BCMA- or CD19-directed autologous CAR T-cell therapies after receiving reports of secondary blood cancers in patients …
The U.S. Food and Drug Administration on Tuesday approved a new tool that uses genetic testing to help assess whether certain people are at risk for developing opioid use disorder. …
Okugan MALVERN, Pa., Dec. 21, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN) is a biotechnology company focused on the discovery, development and commercialization of novel …
4D Molecular Therapeutics Inc. The designation follows interim Phase 1 PRISM clinical data for 4D-150 that demonstrated an encouraging safety, tolerability and clinical activity profile in patients with wet age-related …